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1. Introduction
Food materials that prevent and treat diseases are usually named as functional foods, designer
foods, pharma foods and nutraceuticals [1]. Food has been used since ages as a source for the
treatment and prevention of various disorders. Enrichment of table salt with iodine and wheat
flour with iron/folic acid has been used with an intention to prevent iodine deficiency goiter
and anemia for long. Similarly, food fortified with vitamin A has been found to be a feasible
and cost-effective approach to reduce vitamin A deficiency [2].
Nutraceuticals very often named as “ functional foods ” provides the body with the essential
amount of vitamins, fats, proteins and carbohydrates necessary for healthy survival. When
functional food assists in the prevention and/or treatment of disease (s) other than deficiency
conditions like anemia it is called a “ nutraceutical ” [3].
Nutritional therapy is a healing system using nutraceuticals or phytonutrients for the im‐
provement of human health. It is well known that ancient civilizations used herbal products
as a remedy for many diseases. However, specific term for a formulation describing food or
its active ingredients, which have medicinal values, was eagerly required. Then, in 1989 term
" Nutraceutical " was coined by merging the terms " Nutrition " and " Pharmaceutical " by Dr
Stephen DeFelice [4]. “ Nutraceutical ” is a term used for nutritional supplement that is in the
market with the objective to treat or prevent disease [5].Therefore, a “nutraceutical” is any
matter that may be considered a food or part of a food and provides medical or health benefits.
These food products may be categorized as isolated nutrients, dietary supplements and diets
to genetically engineered "designer " foods, herbal products and processed foods such as
cereals, soups and beverages [6]. Dietary supplements play a vital role in premature chronic
disease appearance, disease progression, morbidity and mortality. Approximately 40-50%
proportion in cardiovascular disorders, 35-50% proportion in cancers, and 20% proportion in
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osteoporosis is attributable to dietary factors [7]. These phytonutrients have a big market
currently and annual growth rates of nutraceuticals are predicted to increase. This rate
expected to be up to 25% for some products [8].
Nutraceuticals include many food and food products, including vitamins, soy products,
glucosamine, chondroitin, and many polyphenols and flavonoids (resveratrol, ellagic acid, and
quercetin). The vast majority of nutraceuticals are extracted from plant origins; such as fruits,
vegetables, roots, and rhizomes. However, many nutraceuticals are derived from animal
origins; vitamins and amino acids [9].
However these nutraceuticals suffer from poor solubility and subsequently bioavailability
which hinders their formulation as well as utility. The cocrystallization of these nutraceutical
is one of the novel strategies to overcome these problems. Cocrystallization of active pharma‐
ceutical ingredients (APIs) with cocrystal formers (or coformers) has gained significant interest
in drug-development since the resulting new solid forms are characterized by different
physicochemical properties compared to the original API. The presence of many functional
groups in APIs, which may form strong supramolecular synthons such as acid...acid,
acid...pyridine, acid...amide, amide...amide, amide...pyridine N-oxide, O-H...O, O-H...N, N-
H...O and N-H...N offers a great opportunity to design pharmaceutical cocrystals
[10-15].Certainly, cocrystallization increases the diversity of solid-state forms of an API and
enhances its pharmaceutical properties such as chemical stability, moisture uptake, mechan‐
ical behavior, solubility, dissolution rate and bioavailability. Hence, cocrystallization can
directly impact scientific and legal aspects of drug development by providing alternative solid
dosage forms and extended patent life.
Significant development on discovery of nutraceutical cocrystals has encouraged numerous
studies on cocrystal formation and evaluation. This chapter presents the nutraceuticals
cocrystals along with their preparation and characterization and crucial role in enhancing their
pharmaceutical parameters.
2. Nutraceuticals: Role in therapeutics
Nutraceutical is the combination of “ nutrition ” and “ pharmaceutical ”. In order to modify
and maintain normal physiological function nutraceuticals play an important role. The current
population and the health trends are the main reasons for the growth and development in the
field of nutraceuticals. These nutraceuticals fights against the major health issues of the century
such as obesity, cardiovascular diseases, cancer, osteoporosis, arthritis, diabetes, cholesterol
etc. In a nutshell, ‘ nutraceutical ’ has lead to the new period of medicine and health, in which
the food industry has become a research oriented sector [9].
Consumers being frustrated with the current status of disease-treatment approach with the
modern medicines are seeking alternative safer and beneficial products and the bureaucracy
of managed care makes nutraceuticals particularly appealing. “ Let food be thy medicine and
medicine be thy food ”, quoted by Hippocrates is definitely the precept of today. Nutraceuticals
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are the promising class of natural products that demarcates between food and drugs to fade
[8]. Even though the use of nutraceuticals by people has a long history, lately scientifically
supported nutritional and medical evidence has permitted nutraceuticals to emerge as being
potentially effective [16].
Research is now focused on the examination of nutritional food for their protective and disease
preventing potential [17]. Nowadays research and development area are exploring different
methods for standardization of the nutraceutical compounds or products, carefully develop
and execute clinical studies to provide the health claims and benefits to the consumers as well
as on the nutraceutical companies. Nutraceuticals have proven to be therapeutically active in
the areas starting from common cold, weight problems, sleeping disorders, digestion, blood
pressure, cholesterol control, pain killers, depression, anti-arthritic, cardio vascular diseases,
diabetes ending up with prevention of certain cancers [18-21].
The nutraceuticals which include Polyunsaturated fatty acid (PUFA), Dietary fibres, Polyphe‐
nols, Spices, Prebiotics, Probiotics and Vitamins are the natural food sources (Figure 1) [22,23].
However, these nutraceuticals have high hydrophobicity and are sensitive to external agents
such as air, light and oxidative enzymes which constitute a serious problem for their bioavail‐
ability.This further hamper their formulation and use. At this point their cocrystal can offer an
opportunity to overcome all the issues of nutraceuticals and help in the exponential growth of
nutraceuticals market.Cocrystal of nutraceuticals alone or in combination with other preven‐
tive and/or therapeutic strategies might become effective future drugs against the most
common degenerative diseases. Cocrystals are engineered solids based on the concept of
different forms having desired properties using hydrogen bonds,pi-pi stacking and van der
waals interactions [9]
Figure 1. Types of Nutraceuticals
3. Cocrystallization
Cocrystals are based on crystal engineering approach which involves the concept of forming
new solids (polymorph/solvates and cocrystals/salts) involving non covalent interactions.
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Thus nutraceutical cocrystals are multi-component solid-state assemblies formed between a
nutraceutical and a cocrystal former of GRAS status bound together in the crystal lattice by
any type or combination of non-covalent intermolecular interactions.
Cocrystallization seeks to logically design new form of the nutraceuticals with preferred
properties.Depending upon the various potential groups present in these nutraceutical
molecules, following heterosynthons are possible (Figure 2) [24] :-
 
Figure 2. Typical Hydrogen Bonds Utilized in Cocrystals
Cocrystallization is at present achieved by a number of techniques including solvent evapo‐
ration, dry and wet (solvent drop addition) solid-state grinding, cooling, growth from melts,
and slurry conversion. This section covers the various methods of preparation and character‐
ization of the cocrystals.
Different techniques for the preparation of co crystals (Figure 3) [25] are described below:-
1. Solvent evaporation technique :- This is the most commonly used technique in the field
of cocrystallization, in this technique stoichiometric amount of the conformer and the drug
are dissolved in a common solvent. It is based on the principle that, when different
molecules of complementary functional groups afford hydrogen bonds that are more
favorable than each of the individual molecular components, the product formed is likely
to be thermodynamically favored [26].
2. Solid-state grinding technique :- This technique commonly known as mechanical milling
or neat grinding technique.in this method the two cocrystal formers are taken in stoichio‐
metric amounts and ground together using a mortar and pestle, using a ball mill, or using
a vibratory mill. Normal grinding time ranges from 30-60 min. It has been reported that
cocrystal was first produced by one technique which may be used as seeds to obtain that
cocrystal by another method, thus possibly facilitating XRD structure determination via
single-crystal growth. In another case, cocrystal structure determination was achieved by
preparing only as crystalline powder by grinding [27]
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Although co-crystal formation by solid-state grinding has been known for some time and a
late 19th century report is often cited as the earliest reference to such a procedure, the recent
technique of adding small amounts of solvent during the grinding process has been shown to
enhance the kinetics and facilitate co-crystal formation and as lead to increased interest of solid-
state grinding as a method for co-crystal preparation [28].
 
Figure 3. Techniques for the Preparation of Cocrystals
3. Slurrying technique:-Slurries‐induced formation of cocrystalline phase is among two or
more active solid materials or between the active solid materials and the excipients.
Equimolar proportion of the two coformers are dissolved in small amount of different
solvents at ambient temperature and allowed to stir for some days. The resulting solution
is slowly evaporated at room temperature during 48 hours to promote cocrystallization
[29]..Further the solvent is allowed to decant and the solid material is dried under a flow
of nitrogen for 5 min. The remaining solids can be characterized using powder X-ray
diffraction (PXRD) [30].
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4. Solvent drop technique:-This technique also known as liquid assisted grinding or
kneading, involving the grinding of stoichiometric amounts of coformers assisted with a
small amount of liquid. This method was developed in order to enhance the rate of
cocrystal formation, It also has advantages over solid state grinding such as increased
yield, ability to control polymorph production, better product crystallinity, and applies
to a significantly larger scope of cocrystal formers [31].
5. Supercritical  fluid  technology  :-Supercritical  fluids  is  another  method  by  which
cocrystals  are synthesized.Supercritical  fluid technology allows a single-step genera‐
tion  of  particles  that  are  difficult  or  even  impossible  to  obtain  by  conventional
techniques.The unique properties of different super critical fluids assist in generation
of pure and dried cocrystals. [32]
6. By using intermediate phase:-Cocrystals can be formed also by using intermediate phases.
In the course of time the use of a hydrate or an amorphous phase as an intermediate during
synthesis in a solid-state route has proven successful in forming a cocrystal. Besides this,
the use of a metastable polymorphic form of one cocrystal former can be used. The
metastable form in this technique acts as an unstable intermediate on the nucleation
pathway to a cocrystal.
7. Antisolvent addition:-Antisolvent addition also known as vapor diffusion is the methods
in which antisolvent is used to synthesize cocrystals.This is one of the methods for
precipitation or recrystalization of the two co-crystal former. Solvents consist of buffers
(pH) and organic solvents. For example, in the preparation of co-crystals of aceclofenac
using chitosan, the chitosan solution was prepared by soaking chitosan in glacial acetic
acid. A stoichiometric amount of the drug was suspended in chitosan solution by using
high dispersion homogenizer. Further, the dispersion was added to distilled water or
sodium citrate solution to precipitate chitosan on drug [33].
3.1. Characterization of cocrystals
This of great importance which can be done using different analytical techniques.Characteri‐
zation of cocrystals starts from melting point determination and might end up to the technique
(Figure 4) employed for the determination of cocrystals.
Thermal analysis:- Differential Scanning Calorimetry (DSC) plays a major role in determining
the thermal property testing of cocrystals.DSC is the technique used to observe enthalpy of
melting (pharmaceutical cocrystal an overview)during various crystallization events.
Besides this, DSC has recently been used as a screening tool for rapid cocrystal screening [34,
35].It has also been reported that when theophylline and nicotinamide were cogrinded, and
from the DSC results it observed that an endothermal peak at about 126.4°C decreased and
finally disappeared. A melting endotherm at 171.6°C, which differs from the melting points
of either theophylline (271.4°C) or nicotinamide (128.2° C), which indicates that as the
cogrinding of theophylline and nicotinamide proceeded, a new phase was formed between
theophylline and nicotinamide during the solid- state grinding [36].
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Vibrational spectroscopy:-For the characterization of cocrystals molecular motions by use
of  vibrational  spectroscopy  are  observed.  This  method  includes  infrared  absorption
spectroscopy.Significant changes in the vibrational frequency are observed for the cocrys‐
tals and individual constituents confirming the formation of cocrytals. It can be a very useful
technique in  differentiaiting  cocrystals  from salts  when a  carboxylic  acid  is  involved in
hydrogen bonding [37].
It has been reported that in the case of indomethacin and saccharin cocrystals, the O–H
stretching of the carboxylic acid group in indomethacin and the N–H stretching of cyclic imide
group in saccharin appeared at 3,350.5 and 3,129.1 cm in Indomethacin and saccharin cocrys‐
tals, implied the formation of new phase [38].
 
Figure 4. Characterization of Cocrystals
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Crystallographic methods: - Includes single X- ray diffraction (SXRD) as well as PXRD. The
single X-ray diffraction study offers atomic positions and complete structural information.
Powder X-ray diffraction studies using microcrystalline samples become a necessary tool to
verify the formation of cocrystal in cases where obtaining single crystal suitable for study
becomes bottleneck.SXRD is commonly used as supporting information about the formation
of a new crystalline phase as in the case of Ciprofloxacin and Norfloxacin cocrystallization [39].
Optical microscopy:-Optical microscopy is the technique used to study crystal morphology.
This feature is reflected in the outer appearance of crystals that can be observed by simple hand
lens or microscope. To add on, a detailed study can be performed using polarizing optical
microscopy, electron microscopy and thermal microscopy.Scanning electron microscopy
(SEM), is also used to characterize the surface morphology of the particles. SEM images a
sample by scanning it with a high-energy beam of electrons in a raster scan pattern. It is applied
to determine the cocrystal micrograph and determine the particle morphology in many
examples [40-43].
Solid-state nuclear magnetic resonance - These days solid-state NMR is also used for charac‐
terization. It studies the chemical environment of the nuclei which is different in cocrystals
because of magnetic non-equivalence. In different cocrystals, resonance peaks for the mag‐
netically non-equivalent nuclei will differ. Dipolar correlation experiments between spin pairs
such as1H-1H,1H-13C, and19F-13C are useful to study hydrogen bonding, intermolecular
contacts, and spin diffusion to connect individual molecules together in a crystal structure and
rapidly establish molecular association [44].
3.2. Case studies of some nutraceutical cocrystals
Nutraceuticals such as flavonoids and vitamins have been investigated as candidates for
cocrystallization studies to improve their pharmaceutical properties [45].
Flavonoids are natural products and are often studied because of their potent antioxidant and
free radical scavenging activities. Nutraceutical cocrystals are associated with higher in vitro
dissolution rate and in vivo bioavailability of their other solid forms, as reported by Smith et
al. for quercetin [46] and Epigallocatechin gallate (EGCG). [47].
It has been reported that cocrystallization of flavonoids with 1,4-diazobicyclo [2.2.2]octane
(DABCO) resulted in increase in the complexity of these molecules as the number of substitu‐
ents on the flavonoid backbone increased. Various preparation and properties of flavonoid
interactions to the formation of cocrystals with APIs were reported [48].
3.2.1. Protocatechuic acid
Protocatechuic acid (3,4-dihydroxybenzoic acid, Figure 5) is a phenolic acid and belongs to
class of polyphenols (Nutraceutical). Protocatechuic acid imparts various pharmacological
activity and these effects are due to their antioxidant activities, along with other possible
mechanisms, such as anti-inflammatory properties and interaction with several enzymes.
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Figure 5. Protocatechuic Acid
S.NO. Co-former PA* + Co-Former
1 Caprolactam
2 Isonicotinamide
3 Isonicotinic Acid
4 Theophylline
Table 1. Single crystals of Protocatechuric acid with different coformers [49]
Cocrystallization in Nutraceuticals
http://dx.doi.org/10.5772/59365
177
Further in this context, novel 1:1 cocrystals of protocatechuic acid (strong antioxidant) with
pharmaceutically accepted molecules (cocrystal formers) such as caprolactam, isonicotina‐
mide, isonicotinic acid, theophylline, nicotinamide and theobromine (Table No. 1) have been
obtained by slow evaporation of stoichiometric amounts of starting materials in an appropriate
solvent and they were removed from their mother liquors before complete evaporation of the
solvent. Cocrystallization via grinding and slurry conversion was also successful to produce
1:1 cocrystals of protocatechuic acid with caprolactam, isonicotinamide, isonicotinic acid,
theophylline, nicotinamide and theobromine. The resultant cocrystals were characterized by
FTIR, DSC, PXRD, single crystal X-ray diffraction and TGA. [49]
3.2.2. Quercetin
Quercetin (3,3',4',5-7-pentahydroxyflavone) (Figure 6), chemically similar to the glycoside
rutin, is a unique flavonoid that has been extensively studied by researchers. It has shown to
be therapeutically useful in allergic conditions, including asthma and hay fever, eczema, and
hives. The frequent link is its ability to mediate production and manufacture of pro-inflam‐
matory compounds.Cocrystal of Quercetin, isonicotinic acid and water (1:1:1) and cocrystal of
quercetin, theobromine and water (1:1:2) were obtained (Table no. 2). Quercetin theobromine
dihydrate cocrystal resulted in 1.5 fold increase in solubility of quercetin. Quercetin-caffeine-
methanol cocrystal was observed after 30 days of slow evaporation of the Quercetin-caffeine-
methanol cocrystal solvate.The resulting crystal structure of single crystal of quercetin-
caffeine-methanol cocrystal solvate showed that the imide group and the aromatic nitrogen of
caffeine interact with the hydroxyl groups of quercetin [50].
O
OH
OH
OH
HO
OH
Figure 6. Quercetin
In another attempt for the synthesis of cocrystal of Quercetin with isonicotinamide, quercetin
dehydrate and isonicotinamide are dissolved in methanol (5 ml) and heated until a clear
solution was obtained. Slow evaporation of this solution in refrigerator resulted in 1:1 crystals
after 2 days. Isonicotinamide molecules interact with quercetin molecules via, CO...OH and
NH...OH supramolecular heterosynthons and OH...OH supramolecular homosynthons. [50]
Four cocrystals of quercetin (QUE): quercetin: caffeine (QUECAF), quercetin: caffeine:
methanol (QUECAF· MeOH), quercetin: Isonicotinamide (QUEINM) and quercetin: theobro‐
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mine dihydrate (QUETBR·2H2O) were prepared by slow evaporation (solution crystallization)
method and each of these cocrystals exhibited pharmacokinetic properties that are superior to
those of quercetin alone. The QUECAF and QUECAF·MeOH cocrystals increased the solubility
of QUE by 14-and 8-fold when compared to QUE dihydrate. Further, the cocrystals outper‐
formed QUE dihydrate with increases in bioavailability up to nearly 10-fold [51].
3.2.3. Hesperetin
Hesperetin (Figure 7) which is the aglycone part of hesperedin and is therapeutically very
potential molecule as it shows antioxidant, antiallergic, antimutagenic and in vitro studies anti
cancer activity. Cocrystallization of hesperetin with isonicotinamide resulted in a 1:1 cocrystal.
The supramolecular synthon formed in the cocrystal includes OH---N hydrogen bond between
the nitrogen atom of isonicotinamide and the OHa of the adjacent hesperetin molecule.
Crystallization of hesperetin with nicotinic acid results in two 1:1 cocrystals in which the
nicotinic acid exists as a zwitterionic state. Cocrystallization has lead to the generation novel
cocrystals of hesperetin with pharmaceutically acceptable molecules such as isonicotinamide
and nicotinic acid [52].
3.2.4. Pterostilbene
Pterostilbene (Figure 8) is also a nutraceutical which is found in nature in a number of tree
barks and a variety of berries, including grapes, as well as plants commonly used in traditional
folk medicine. Cocrystals of pterostilbene comprises of coformers such as: caffeine, carbama‐
zepine. Three cocrystals of a 1:1 stoichiometric molar ratio of pterostilbene with caffeine and
carbamazepine were obtained and characterized by crystallographic (XRPD, single-crystal)
and thermoanalytical (TGA, DSC) techniques. Physical stability of the reported cocrystals with
respect to relative humidity was established to be significantly improved in relationship to
S.NO. Co-Former Quercetin + co-Former
1 Isonicotinic acid + water
2 Theobromine + water
Table 2. Co- crystals of Quercetin with different coformers [50]
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S.NO. Co-Former Single crystal of Hesperetin +conformer
1 Isonicotinamide
2 Nicotinic acid.
Table 3. C ocrystalsof Hesperetin with different coformers [52]
O
OH
OH
OH
HO
OH O
Figure 7. Hesperetin
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caffeine or carbamazepine. The carbamazepine: pterostilbene cocrystal was found to be stable
upon slurrying in water for 3 days and its solubility was 7× lower than carbamazepine
dihydrate and 2.5× lower than pterostilbene [53].
Another study on pterostilbene cocrystallization with pharmaceutically acceptable coformers
piperazine and glutaric acid was reported by Bethune et al. [54]. Cocrystals of a 2:1 and 1:1
stoichiometric molar ratio of pterostilbene with piperazine or glutaric acid were synthesized
and evaluated for physical stability with respect to humidity and temperature as well as kinetic
solubility.The pterostilbene/piperazine cocrystal disclose a 6-fold increase in pterostilbene
concentration compared with the solubility of pterostilbene.
Figure 8. Pterostilbene
3.2.5. p-Coumaric
p-Coumaric (Figure 9) acid is a phytochemical and nutraceutical compound.Cocrystals
synthesized with p-coumaric acid are explored with xanthine compounds, caffeine and
theophylline. Four cocrystals of p-Coumaric acid with caffeine (1: 1 and 1: 2 stoichiometric
ratios) and was synthesized and their structures determined by single-crystal X-ray crystal‐
lography. The two theophylline cocrystals display synthon polymorphism, where both
structures possess a carboxylic acid–imidazole heteromeric synthon [55].
In another work reported for polymorphic cocrystals of p-Coumaric acid, the nutraceutical
was cocrystallized with nicotinamide, producing three polymorphic 1:1 cocrystals and one 2:1
(p-Coumaric acid-nicotinamide) cocrystal. Conversion of the 1:1 cocrystals to the 2:1 cocrystal
in water was revealed by in situ dispersive Raman spectroscopy. An enantiotropic relationship
is believed to be existing between two of the 1:1 cocrystals; the third polymorph was likely to
be metastable [56].
3.2.6. Curcumin
Curcumin, the most important curcuminoid extracted from Curcuma longa rhizomes, was
commonly used as a spice until its medicinal properties in Indian and Chinese systems of
medicine were known and documented.Curcumin (Figure 6) is extensively used as a drug but
its utility is hindered due to poor aqueous solubility.
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It has been reported that the cocrystals of curcumin with resorcinol and pyrogallol were
obtained by solvent drop method. Cocrystals of Curcumin–resorcinol and curcumin–pyro‐
gallol were obtained in stoichiometric ratio of 1: 1and were characterized by X-ray diffraction,
thermal analysis, FT-IR, FT-Raman, and solid-state 13C NMR spectroscopy. The melting point
of the cocrystals was found to be between that of curcumin and the conformer,it has been
observed that the lower melting cocrystal was more soluble than higher melting.The dissolu‐
tion studies revealed that the dissolution rates of curcumin–resorcinol and curcumin–
pyrogallol in 40% EtOH–water are ~5 and ~12 times faster than that for curcumin [57].
O OH
OCH3
HO
OCH3
OH
Figure 10. Curcumin
3.2.7. Citric acid
Citric acid (2-hydroxy-1, 2, 3-propanetricar-boxylic acid) is a weak tricarboxylic acid that is
naturally concentrated in citrus fruits. Citric acid is commonly used as a food additive to
provide acidity and sour taste to foods and beverages. Citrate salts of various metals are used
to deliver minerals in biologically-available forms; examples include dietary supplements and
medications. Citric acid is known as a highly soluble and safe nutraceutical. Since citric acid
is highly soluble it may be used as conformer in the field of cocrystallization.
It was reported that Citric acid (Figure 11) and paracetamol in 2:1 stoitiometric ratio formed
cocrystals. Notable changes were observed in the IR spectra of the cocrystal. IR spectra of
cocrystal were different from that of the raw materials by several vibrational frequencies. The
asymmetric unit of the crystal has two paracetamol molecules hydrogen-bonded to the citric
acid; one of these behaves as a phenolic-OH hydrogen bond donor to the carbonyl of a
Figure 9. p-Coumaric acid
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carboxylic acid arm of citric acid. In contrast, the other phenolic-OH acts as a hydrogen bond
acceptor from the quaternary C–OH of citric acid [58].
HO
O
OH
O
OH
O OH
Figure 11. Citric acid
Dalia et al., had reported about the formation of a novel cocrystals of citric acid resulting in
the formation of single crystals (Table no. 4). Cocrystal of citric acid in 2:1 ratio with isonico‐
tinamide was reported and X-ray crystal structure indicates that molecules of iso-nicotinamide
form hydrogen bonds with molecules of citric acid [59].
S.NO. Co-Former Single crystal
1. Isonicotinamide
Table 4. Cocrystal of Citric acid
3.2.8. Gossypol
Gossypol (Figure 12) is a natural product occurring as biphenolic compound derived from the
cotton plant (genus Gossypium). Wang et al. in 2009 reported the (-)-gossypol cocrystals with
a C1–8 carboxylic acid or C1–8 sulfonic acid which are inhibitors of anti-apoptotic Bcl-2 family
proteins. The invention also relates to inducing apoptosis in cells and for sensitizing cells to
the induction of apoptotic cell death by the cocrystals of (-)-gossypol with a C1–8 carboxylic
acid or C1–8 sulfonic acid [60].
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Figure 12. Gossypol
3.2.9. Fisetin, Luteolin, Genistein
Fisetin, Luteolin and Genistein (Figure 13) are natural polyphenolic compounds belonging to
nutraceuticals.Crystallization studies were carried on these molecules with nicotinamide and
isonicotinamide as coformers. Five cocrystals were isolated, characterized by X-ray single-
crystal diffraction, FT-Raman spectroscopy, thermal analysis (DSC and TG–DTA), 1H NMR in
solution and compared in terms of supramolecular motifs. Fisetin–nicotinamide (1: 2) ethanol
hemisolvate (FisNam), fisetin–isonicotinamide (1:1) (FisInam), two polymorphic forms of
luteolin–isonicotinamide (1: 1) (LutInam, LutInam2) and genistein–nicotinamide (1:1)
monohydrate (GenNam) cocrystals reveal the presence of an OH.....N (atom) heterosynthon
between an O7 hydroxyl moiety of a flavonoid and the pyridyl ring of a conformer [61].
Figure 13. Fistelin, Luteolin and Genistein
Genistein (Figure 13) is a phytoestrogen and belongs to the category of isoflavones. Genistein
and Caffeine formed 1:1 cocrystalline phase, which was formed by means of a solvent-drop
grinding experiment and isolated later in a solution-evaporation approach. Resulting cocrystal
was characterized by X-ray single-crystal and powder diffraction and the cocrystals were
explored in terms of thermal stability and Hirshfeld surfaces. A scale-up procedure by slurry
method, facilitated solubility studies. Neutral forms of both compounds cocrystallize in a
common P21/c space group of the monoclinic crystal system. Crystal lattice discloses formation
of molecular layers, formed by O–H_ _ _O, O–H_ _ _N and C–H_ _ _O-type contacts between
genistein and caffeine molecules, while stabilization of the three-dimensional crystal lattice is
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offered by pi - pi interactions. Dissolution studies showed maximum solubility of the cocrys‐
talline phase in a 50:50 v/v ethanol–water medium, attained 0.861 mg/mL after 8 h, revealing
some degree of enhancement as compared to parent genistein, maximum solubility of which
was also reached after 8 h and equaled to 0.588 mg/mL [62].
4. Conclusion
These natural products are of interest because of their proposed health-promoting effects as
antioxidants and anticarcinogens. In spite of the immense biological activities revealed by
nutraceuticals still these phytogenes cannot be exploited due to their biopharmaceutical issues
which hinder their utility. However, their high hydrophobicity and sensitivity to external
agents such as air, light and oxidative enzymes constitute a serious problem for their bioa‐
vailability and formulation.. However, bioavailabilty and solubility troubles coupled with
these natural entities can be improved by formulating them into cocrystals. The cocrystalliza‐
tion strategy may optimize some potential nutraceuticals. Cocrystal of nutraceuticals alone or
in combination with other preventive and/or therapeutic strategies might become effective
future drugs against the most common degenerative diseases. Though studies on co crystal‐
lization of nutraceutical molecules are going on, still there is a lot to be explored so as to utilize
these potential molecules for severe disease.
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